Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Co-administration of azithromycin and ivermectin mass drug administration for trachoma and scabies in Choiseul Province
ACTRN12615001199505Phase 4Completed
- Sponsor
- Murdoch Children's Research Institute
- Start
- Sep 2015
- Modality
- Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of azithromycin, ivermectin, permethrin and tetracycline in trachoma and scabies, sponsored by Murdoch Children's Research Institute. Primary endpoint: Mass drug administration coverage. Started Sep 2015; status: completed.
02
Drugs
azithromycinivermectinpermethrintetracycline
03
Conditions
trachomascabies
Beyond the preview
Go deeper on ACTRN12615001199505.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12615001199505.